This book offers a comprehensive overview of neovascular glaucoma (NVG), which is an extraordinarily aggressive type of secondary glaucoma that has often been discussed as an afterthought rather than the focal subject in glaucoma reference books. NVG is considered an end stage complication in patients with certain underlying retinal diseases, most commonly diabetic retinopathy and retinal vein occlusions. Historically, NVG has been one of the most difficult types of glaucoma to manage, with a high failure rate for traditional glaucoma surgery, and often progression of the underlying retinal disease despite “standard of care” treatment. Chapters cover advancements made in recent years in the management of the underlying ischemic retinal conditions that lead to NVG, including the use of anti-vascular endothelial growth factor (anti-VEGF) medications. Additionally, chapters discuss glaucoma surgeries, which have become less invasive in recent years with the advent of microinvasive glaucoma surgery (MIGS). This book offers an up-to-date reference regarding current concepts in the diagnosis, as well as medical, laser, and surgical treatment of NVG in the anti-VEGF era, with attention to the close collaboration between glaucoma specialists and retina specialists.